annb0t
Top 20
New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve therapy selection GE Healthcare's Pharmaceutical Diagnostics business is an established global supplier of PET imaging tracers to the global clinical research market
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/...
>>> Read more: Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/...
>>> Read more: Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market
